AS

Aishwarya Santosh Singh

Active Director Director DIN 10668390
DIN 10668390 First appointment Jun 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Aishwarya Santosh Singh

Data last updated:

Aishwarya Santosh Singh is a Director at Eye Kya Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10668390
Primary Designation Director
Industry Pharma
First Appointment 14 Jun 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Jun 20242024Active

Board colleagues of Aishwarya Santosh Singh

Directorship timeline

Open interactive timeline →
Eye Kya Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Aishwarya Santosh Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aishwarya Santosh Singh

Aishwarya Santosh Singh currently holds 1 directorship: Eye Kya Pharmaceuticals Private Limited (Director, since 14 Jun 2024).

Aishwarya Santosh Singh was first appointed on 14 Jun 2024 as Director at Eye Kya Pharmaceuticals Private Limited.

The current boards of Aishwarya Santosh Singh's companies include Bachu Laxmi Swetha (Eye Kya Pharmaceuticals Private Limited), Ravindra Pratap Singh (Eye Kya Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available